Hypo-fractionated accelerated radiotherapy with concurrent and maintenance temozolomide in newly diagnosed glioblastoma: updated results from phase II HART-GBM trial.
J Neurooncol
; 164(1): 141-146, 2023 Aug.
Article
in En
| MEDLINE
| ID: mdl-37452916
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Brain Neoplasms
/
Glioblastoma
Type of study:
Clinical_trials
/
Diagnostic_studies
Limits:
Humans
Language:
En
Journal:
J Neurooncol
Year:
2023
Document type:
Article
Affiliation country:
India